Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Recruiting 2 Completed 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 11 Breast Neoplasms 2 Salivary Gland Neoplasms 1 Polycystic Ovary Syndrome 1 Neoplasm Metastasis 1 Metabolic Diseases 1 Hyperandrogenism 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Fluorouracil 18 Oxaliplatin 17 Capecitabine 16 Leucovorin 13 Cisplatin 12 Gemcitabine 11 Drug Therapy 11 Irinotecan 10 Radiosurgery 9 Cetuximab 9 Bevacizumab 9 pembrolizumab 8 Docetaxel 8 Everolimus 7 spartalizumab 6 Sunitinib 6 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Cyclophosphamide 6 Trastuzumab 5 S 1 (combination) 5 Nivolumab 5 Immunotherapy 5 Immune Checkpoint Inhibitors 5 Chemotherapy, Adjuvant 5 Carboplatin 5 palbociclib 4 manganese chloride 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × bicalutamide × Clear all

NCT02353988 2015-02-03

Arbre

Jinling Hospital, China

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡